Page last updated: 2024-08-25

lycorine and Idiopathic Parkinson Disease

lycorine has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cai, CZ; Chen, JY; Chen, Y; Lu, JH; Su, HX; Tan, JQ; Yuan, NN; Zhu, Q; Zhuang, XX1

Other Studies

1 other study(ies) available for lycorine and Idiopathic Parkinson Disease

ArticleYear
Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 87

    Topics: alpha-Synuclein; Amaryllidaceae Alkaloids; Animals; Autophagy; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Humans; Male; Mice, Transgenic; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Phenanthridines; Proteasome Endopeptidase Complex; Rats; Ubiquitin; Up-Regulation

2021